Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 82 of 82 entries
View as:

Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD

Phase: N/A Priority: Normal
NCT ID: NCT03012646 Org: User:
Start: 04/30/17 End: 04/30/19 Due: 04/30/20

FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)

Phase: N/A Priority: Normal
NCT ID: NCT00760916 Org: User:
Start: 12/31/08 End: 01/31/09 Due: 01/31/10

A Pharmacokinetic Substudy of the TDE-PH-304 Protocol

Phase: N/A Priority: Normal
NCT ID: NCT01934582 Org: User:
Start: 08/31/13 End: 11/30/13 Due: 11/30/14

An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01560637 Org: User:
Start: 09/11/13 End: 08/12/21 Due: 08/12/22

Pulmonary Hypertension Screening in Patients with Interstitial Lung Disease for Earlier Detection

Phase: N/A Priority: Normal
NCT ID: NCT05776225 Org: User:
Start: 08/11/23 End: 06/30/25 Due: 06/30/26

Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment Satisfaction

Phase: N/A Priority: Normal
NCT ID: NCT00458042 Org: User:
Start: 03/31/07 End: 11/30/07 Due: 11/30/08

An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE

Phase: N/A Priority: Normal
NCT ID: NCT02633293 Org: User:
Start: 09/15/16 End: 08/01/21 Due: 08/01/22